Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections

Population Pharmacokinetic and Pharmacodynamic Analysis for Maximizing the Effectiveness of Ceftobiprole in the Treatment of Severe Methicillin-Resistant Staphylococcal Infections

Ceftobiprole is a fifth-generation cephalosporin used for different Gram-positive bacterial infections. A population pharmacokinetic analysis was conducted in real-life clinical patients to assess the adequacy of current dosages. Population pharmacokinetics was conducted using non-linear mixed effec...

Full description

Bibliographic Details
Main Authors:	Pier Giorgio Cojutti, Simone Giuliano, Renato Pascale, Jacopo Angelini, Carlo Tascini, Pierluigi Viale, Federico Pea
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Series:	Microorganisms
Subjects:	ceftobiprole population pharmacokinetics MRSA infection MRSE infection
Online Access:	https://www.mdpi.com/2076-2607/11/12/2964

Similar Items

Ceftobiprole for the treatment of infective endocarditis: A case series
by: Carlo Tascini, et al.
Published: (2020-03-01)

Ceftobiprole Perspective: Current and Potential Future Indications
by: Tommaso Lupia, et al.
Published: (2021-02-01)

Ampicillin and Ceftobiprole Combination for the Treatment of <i>Enterococcus faecalis</i> Invasive Infections: “The Times They Are A-Changin”
by: Simone Giuliano, et al.
Published: (2023-05-01)

Real-life experience with ceftobiprole in a tertiary-care hospital
by: Emanuele Durante-Mangoni, et al.
Published: (2020-09-01)

Marinopyrrole Derivatives as Potential Antibiotic Agents against Methicillin-Resistant Staphylococcus aureus (II)
by: Rongshi Li, et al.
Published: (2013-08-01)

A case report of treatment of a streptococcal brain abscess with ceftobiprole supported by the measurement of drug levels in the cerebrospinal fluid
by: Simone Giuliano, et al.
Published: (2024-03-01)

Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014–2015
by: Santerre Henriksen A, et al.
Published: (2018-08-01)

Ceftobiprole: a potential empirical post-operative monotherapy in prosthetic joint infections
by: Claire Duployez, et al.
Published: (2020-03-01)

Efficiency of Antimicrobial Peptides Against Multidrug-Resistant Staphylococcal Pathogens
by: Mi Nguyen-Tra Le, et al.
Published: (2022-06-01)

In Vitro Antibacterial Activity of Ceftobiprole and Comparator Compounds against Nation-Wide Bloodstream Isolates and Different Sequence Types of MRSA
by: Lingqin Li, et al.
Published: (2024-02-01)

Susceptibility of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2019 from different European territories
by: Stephen Hawser, et al.
Published: (2022-06-01)

Surveillance of ceftobiprole against Gram-positive and Gram-negative clinical isolates from 2018 from different European territories
by: Stephen Hawser, et al.
Published: (2021-09-01)

In Vitro Activities of Ceftobiprole, Dalbavancin, Tedizolid and Comparators against Clinical Isolates of Methicillin-Resistant <i>Staphylococcus aureus</i> Associated with Skin and Soft Tissue Infections
by: Sofia Maraki, et al.
Published: (2023-05-01)

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
by: Dana Binyamin, et al.
Published: (2018-06-01)

Combination antimicrobial therapy: in vitro synergistic effect of anti-staphylococcal drug oxacillin with antimicrobial peptide nisin against Staphylococcus epidermidis clinical isolates and Staphylococcus aureus biofilms
by: Toktam Sharafi, et al.
Published: (2024-01-01)

Ceftobiprole for Treatment of MRSA Blood Stream Infection: A Case Series
by: Mahmoud E, et al.
Published: (2020-08-01)

Cefto Real-Life Study: Real-World Data on the Use of Ceftobiprole in a Multicenter Spanish Cohort
by: Carmen Hidalgo-Tenorio, et al.
Published: (2023-07-01)

Ceft-to-Ceft Study: Real-Life Experience with Ceftaroline and Ceftobiprole in Treatment of the Principal Infectious Syndromes in a Spanish Multicenter Hospital Cohort
by: Daniel Arnés García, et al.
Published: (2023-12-01)

Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials
by: Thomas W. L. Scheeren, et al.
Published: (2019-02-01)

Study of Degradation Kinetics and Structural Analysis of Related Substances of Ceftobiprole by HPLC with UV and MS/MS Detection
by: Dariusz Boczar, et al.
Published: (2022-12-01)

Unveiling the Relationship between Ceftobiprole and High-Molecular-Mass (HMM) Penicillin-Binding Proteins (PBPs) in <i>Enterococcus faecalis</i>
by: Paola Conti, et al.
Published: (2024-01-01)

Investigation of the Affinity of Ceftobiprole for Selected Cyclodextrins Using Molecular Dynamics Simulations and HPLC
by: Dariusz Boczar, et al.
Published: (2023-11-01)

Biofilm Formation in Methicillin-Resistant Staphylococcus aureus Isolated in Cystic Fibrosis Patients Is Strain-Dependent and Differentially Influenced by Antibiotics
by: Agathe Boudet, et al.
Published: (2021-10-01)

Protective Face Mask Filter Capable of Inactivating SARS-CoV-2, and Methicillin-Resistant <em>Staphylococcus aureus</em> and <em>Staphylococcus epidermidis</em>
by: Miguel Martí, et al.
Published: (2021-01-01)

Ceftobiprole Medocaril Is an Effective Post-Exposure Treatment in the Fischer 344 Rat Model of Pneumonic Tularemia
by: Mark M. Hahn, et al.
Published: (2023-08-01)

A new approach to interior lighting design :early stage research in Ireland
by: James Duff, et al.
Published: (2014-12-01)

Impact of PBP4 Alterations on β-Lactam Resistance and Ceftobiprole Non-Susceptibility Among Enterococcus faecalis Clinical Isolates
by: Lorenzo M. Lazzaro, et al.
Published: (2022-01-01)

New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended
by: Alessandra Oliva, et al.
Published: (2023-12-01)

Efficacy of ceftaroline and rifampin, alone or combined, in a rat model of methicillin-resistant Staphylococcus epidermidis osteomyelitis without implant
by: S. Albac, et al.
Published: (2023-12-01)

Antimicrobial Synergistic Effects of Linezolid and Vancomycin with a Small Synthesized 2-Mercaptobenzothiazole Derivative: A Challenge for MRSA Solving
by: Marilena Muraglia, et al.
Published: (2023-08-01)

Early recognition of methicillin-resistant Staphylococcus aureus surgical site infections using risk and protective factors identified by a group of Italian surgeons through Delphi method
by: G. Sganga, et al.
Published: (2017-06-01)

Enhancement after small-incision lenticule extraction
by: Liu, Yu-Chi, et al.
Published: (2019)

Stethoscopes or Maybe “Bacterioscopes” – Is hand Hygiene Solely Capable of Preventing Hospital-Associated Infections?
by: TALAGA-ĆWIERTNIA KATARZYNA, et al.
Published: (2023-03-01)

Different evolution of S. aureus methicillin-resistant and methicillin-susceptible infections, Argentina
by: Danilo Barcudi, et al.
Published: (2024-01-01)

Current role of community-acquired methicillin-resistant Staphylococcus aureus among children with skin and soft tissue infections
by: Carlos G. Teran, et al.
Published: (2012-01-01)

Community-Associated Methicillin-Resistant Staphylococcus aureus, Iowa, USA
by: Philip Van De Griend, et al.
Published: (2009-10-01)

Utility of Methicillin-Resistant <i>Staphylococcus aureus</i> Nares Screening in Hospitalized Children with Acute Infectious Disease Syndromes
by: Ashley Sands, et al.
Published: (2021-11-01)

Methicillin-Resistant Staphylococcus Aureus (mrsa) as a Cause of Nosocomial Wound Infections
by: Maida Šiširak, et al.
Published: (2010-02-01)

Evaluation of antibiotic activity of methicillin in healing of full-thickness infected wounds with sensitized methicillin resistant Staphylococcus aureus in presence of HAMLET
by: Amir Amniattalab, et al.
Published: (2018-10-01)

In vitro evaluation of methicillin-resistant and methicillin-sensitive Staphylococcus aureus susceptibility to Saudi honeys
by: Muhammad Barkaat Hussain, et al.
Published: (2019-07-01)